391 related articles for article (PubMed ID: 35800371)
21. C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance.
Li G; Hu X; Sun L; Li X; Li J; Li T; Zhang X
Cell Mol Biol Lett; 2018; 23():6. PubMed ID: 29483928
[TBL] [Abstract][Full Text] [Related]
22. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of altered sequestration and efflux of chemotherapeutic drugs by multidrug-resistant cells.
Ouar Z; Lacave R; Bens M; Vandewalle A
Cell Biol Toxicol; 1999 Apr; 15(2):91-100. PubMed ID: 10408356
[TBL] [Abstract][Full Text] [Related]
24. Nanodrug delivery in reversing multidrug resistance in cancer cells.
Kapse-Mistry S; Govender T; Srivastava R; Yergeri M
Front Pharmacol; 2014; 5():159. PubMed ID: 25071577
[TBL] [Abstract][Full Text] [Related]
25. Molecular Modeling Strategies of Cancer Multidrug Resistance.
Yalcin-Ozkat G
Drug Resist Updat; 2021 Dec; 59():100789. PubMed ID: 34973929
[TBL] [Abstract][Full Text] [Related]
26. The medicinal chemistry of multidrug resistance (MDR) reversing drugs.
Teodori E; Dei S; Scapecchi S; Gualtieri F
Farmaco; 2002 May; 57(5):385-415. PubMed ID: 12058813
[TBL] [Abstract][Full Text] [Related]
27. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.
Sikic BI; Fisher GA; Lum BL; Halsey J; Beketic-Oreskovic L; Chen G
Cancer Chemother Pharmacol; 1997; 40 Suppl():S13-9. PubMed ID: 9272128
[TBL] [Abstract][Full Text] [Related]
28. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
[TBL] [Abstract][Full Text] [Related]
29. The multiple mechanisms of multidrug resistance and cellular pH.
Simon S
Novartis Found Symp; 2001; 240():269-81; discussion 282-9. PubMed ID: 11727935
[TBL] [Abstract][Full Text] [Related]
30. [Multidrug resistance (MDR) in oncology].
Souvirón Rodríguez A; Ruiz Gómez MJ; Morales Moreno JA; Martínez Morillo M
An Med Interna; 1997 Mar; 14(3):145-53. PubMed ID: 9235086
[TBL] [Abstract][Full Text] [Related]
31. Reversal of multidrug resistance of tumor cells.
Szabó D; Keyzer H; Kaiser HE; Molnár J
Anticancer Res; 2000; 20(6B):4261-74. PubMed ID: 11205256
[TBL] [Abstract][Full Text] [Related]
32. Asclepiasterol, a novel C21 steroidal glycoside derived from Asclepias curassavica, reverses tumor multidrug resistance by down-regulating P-glycoprotein expression.
Yuan WQ; Zhang RR; Wang J; Ma Y; Li WX; Jiang RW; Cai SH
Oncotarget; 2016 May; 7(21):31466-83. PubMed ID: 27129170
[TBL] [Abstract][Full Text] [Related]
33. Structure-activity relationships of multidrug resistance reversers.
Wiese M; Pajeva IK
Curr Med Chem; 2001 May; 8(6):685-713. PubMed ID: 11281849
[TBL] [Abstract][Full Text] [Related]
34. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance.
Gekeler V; Boer R; Uberall F; Ise W; Schubert C; Utz I; Hofmann J; Sanders KH; Schächtele C; Klemm K; Grunicke H
Br J Cancer; 1996 Sep; 74(6):897-905. PubMed ID: 8826855
[TBL] [Abstract][Full Text] [Related]
35. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
[TBL] [Abstract][Full Text] [Related]
36. Transporter-mediated multidrug resistance and its modulation by Chinese medicines and other herbal products.
Wang Z; Ravula R; Cao M; Chow M; Huang Y
Curr Drug Discov Technol; 2010 Mar; 7(1):54-66. PubMed ID: 20156136
[TBL] [Abstract][Full Text] [Related]
37. Intracellular drug sequestration events associated with the emergence of multidrug resistance: a mechanistic review.
Duvvuri M; Krise JP
Front Biosci; 2005 May; 10():1499-509. PubMed ID: 15769640
[TBL] [Abstract][Full Text] [Related]
38. SERCA and P-glycoprotein inhibition and ATP depletion are necessary for celastrol-induced autophagic cell death and collateral sensitivity in multidrug-resistant tumor cells.
Xu SW; Law BYK; Qu SLQ; Hamdoun S; Chen J; Zhang W; Guo JR; Wu AG; Mok SWF; Zhang DW; Xia C; Sugimoto Y; Efferth T; Liu L; Wong VKW
Pharmacol Res; 2020 Mar; 153():104660. PubMed ID: 31982489
[TBL] [Abstract][Full Text] [Related]
39. Reversion of P-glycoprotein-mediated multidrug resistance in human leukemic cell line by carnosic acid.
Yu XN; Chen XL; Li H; Li XX; Li HQ; Jin WR
Chin J Physiol; 2008 Dec; 51(6):348-56. PubMed ID: 19280878
[TBL] [Abstract][Full Text] [Related]
40. A novel flavonoid from Fissistigma cupreonitens, 5‑hydroxy‑7,8‑dimethoxyflavanone, competitively inhibited the efflux function of human P-glycoprotein and reversed cancer multi-drug resistance.
Teng YN; Lin KI; Lin YC; Thang TD; Lan YH; Hung CC
Phytomedicine; 2021 May; 85():153528. PubMed ID: 33735724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
